We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Vytorin Cholesterol Drug ANDA Leads to Mylan Patent Dispute
Vytorin Cholesterol Drug ANDA Leads to Mylan Patent Dispute
January 5, 2010
Mylan Pharmaceuticals, which submitted an ANDA for a generic version of Schering’s cholesterol drug Vytorin, has been sued by Schering and MSP Singapore.